Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Eslicarbazepine Acetate (Zebinix) is an anticonvulsant medication approved for use in Europe, the United States and Canada as an adjunctive therapy for partial-onset seizures that are not adequately controlled with conventional therapy.
説明 | Eslicarbazepine Acetate (Zebinix) is an anticonvulsant medication approved for use in Europe, the United States and Canada as an adjunctive therapy for partial-onset seizures that are not adequately controlled with conventional therapy. |
別名 | Zebinix, Aptiom, BIA 2-093, Exalief, Stedesa |
分子量 | 296.32 |
分子式 | C17H16N2O3 |
CAS No. | 236395-14-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 9 mg/mL (30.4 mM)
DMSO: 55 mg/mL (185.6 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Eslicarbazepine Acetate 236395-14-5 Membrane transporter/Ion channel Neuroscience Sodium Channel Beta-Secretase Na channels Beta-secretase Eslicarbazepine Zebinix BACE inhibit Na+ channels Aptiom BIA 2-093 β-Secretase Inhibitor Exalief Stedesa inhibitor